Drug Shortage Report for VARIVAX III

Last updated on 2023-07-14 History
Report ID 195572
Drug Identification Number 02246081
Brand name VARIVAX III
Common or Proper name varicella virus vaccine, live, attenuated [Oka/Merck]) Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 1350UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1x vial
ATC code J07BK
ATC description VIRAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2023-06-19
Actual start date 2023-06-21
Estimated end date 2023-07-14
Actual end date 2023-07-13
Shortage status Resolved
Updated date 2023-07-14
Company comments Remaining doses are reserved for the public immunization program. 10x image remains available for private orders.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-07-14 English Compare
v11 2023-07-13 French Compare
v10 2023-07-13 English Compare
v9 2023-06-29 French Compare
v8 2023-06-29 English Compare
v7 2023-06-20 French Compare
v6 2023-06-19 French Compare
v5 2023-06-19 English Compare
v4 2023-06-19 French Compare
v3 2023-06-19 English Compare
v2 2023-06-19 French Compare
v1 2023-06-19 English Compare

Showing 1 to 12 of 12